S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
Monique Garbarg, Jean‐Michel Arrang, Agnès Rouleau et al. · Journal of Pharmacology and Experimental Therapeutics · 1992
Cited by 157 works. doi:10.1016/s0022-3565(25)10340-6
Authors
- Monique Garbarg
- Jean‐Michel Arrang
- Agnès Rouleau
- Xavier Ligneau
- M. Dam Trung Tuong
- Jean‐Charles Schwartz
- C. Robin Ganellin
References
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
- PHARMACOLOGICAL ESTIMATION OF DRUG-RECEPTOR DISSOCIATION CONSTANTS. STATISTICAL EVALUATION. I. AGONISTS
- Highly potent and selective ligands for histamine H3-receptors
- Histaminergic transmission in the mammalian brain
- Chemical differentiation of histamine H1- and H2-receptor agonists
- PHARMACOLOGICAL ESTIMATION OF DRUG-RECEPTOR DISSOCIATION CONSTANTS. STATISTICAL EVALUATION. II. COMPETITIVE ANTAGONISTS
- Molecular cloning of a gene encoding the histamine H2 receptor.
- Autoregulation of histamine release in brain by presynaptic H3-receptors